Age, weight, and sex are meaningful modifiers of IGE risk
We commonly work with individuals who: Are starting or currently taking a GLP-1 medication Want help managing side effects such as nausea, low appetite, or fatigue Are concerned about muscle loss or inadequate nutrient intake Want guidance on how much and what to eat while on medication Are preparing to taper or transition off a GLP-1 medication Wherever you are in the process, we meet you there
Bernerd F, Passeron T, Castiel I, Marionnet C
In future RCTs, key considerations such as the optimal timing of intervention, treatment duration, specific patient subgroups based on molecular diagnosis, and potential systemic adverse events require further investigation
Clinical criteria can be found on the Aetna public site for providers
@neverboringever "My friend almost died on July 3rd from anaphylactic shock five minutes after injecting an injectable peptide